Wednesday, 14 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 25, 2026

Anthony Scaramucci on Trump Slump and crypto crash

View original at finance.yahoo.com
Anthony Scaramucci on Trump Slump and crypto crash Opening Bid Unfiltered is available on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Federal Reserve could cut 100 basis points this year despite current stance

    80% confidence
  • Tariffs hurt manufacturing and the trade deficit contrary to Trump's stated goals

    80% confidence
  • 480 stocks in the S&P have already had a repricing moment while 20 stocks hold up the market

    80% confidence
  • Each American was hit with $1,300 to $1,700 in tariff surcharges last year

    80% confidence
  • Kevin Warsh deserves to be approved as Fed Chair and will be approved

    80% confidence
  • The Pokemon Illustrator card has dramatically outperformed the S&P 500 over 28 years

    80% confidence
  • Buy quality and stay patient is the key investment advice from 40 years of professional investing

    80% confidence
  • There will never be another Pokemon Illustrator card graded PSA 10

    80% confidence
  • All major AI platforms (ChatGPT, Anthropic Claude, Google Gemini) conclude Bitcoin will be needed as neutral currency in age of AI

    80% confidence
  • Some on Wall Street are calling recent market conditions the 'Trump Slump'

    80% confidence
  • Bitcoiners will have won when you can custody Bitcoin at Bank of America or JPMorgan

    80% confidence
  • MicroStrategy can hold Bitcoin regardless of stock price due to capital structure with 2-year cash fortress

    80% confidence
  • AJ Scaramucci bought JPMorgan at $25 in 2005 when he was 13, now trading at $250-260

    80% confidence
  • Institutions have been good for crypto on the margin but not as deep as some pundits claim

    80% confidence
  • This is a garden variety crypto winter based on the 4-year Bitcoin halving cycle

    80% confidence
  • Tourism to US is way down with 25% drop in Canadian tourism to Florida

    80% confidence
  • Bitcoin is neutral and native to the internet, needed as store of value in age of AI

    80% confidence
  • Massive wave of institutional Bitcoin exposure won't come until Clarity Act is passed

    80% confidence
  • Criminal case against Jerome Powell will need to be dropped for Warsh confirmation

    80% confidence
  • Currently buying Bitcoin in the mid-sixties range

    80% confidence
  • The purchase of the $16.5 million Pokemon card generated about $200 million worth of media exposure

    80% confidence
  • Markets like evenness, predictability, and stability which Trump's knee-jerk tariff policy disrupts

    80% confidence
  • In 34 years, Bitcoin will be at very high prices and people will regret not buying in mid-60s

    80% confidence
  • AI will boost productivity and is a phenomenon driving future economic growth

    80% confidence
  • MicroStrategy's MNA of 1.22 indicates we're near a Bitcoin bottom

    80% confidence
  • Market slump will be temporary and mild, not steep

    80% confidence
  • Ken Goldin pointed out the Scaramucci family buys one significant collectible every 10 years

    80% confidence
  • Bitcoin could go to $50,000 but there's price support in the low to mid-sixties

    80% confidence
  • If Bitcoin goes to $8,000, MicroStrategy will refinance everything

    80% confidence
  • The Supreme Court ruling against tariffs was correct because tariffs are taxation without representation

    80% confidence

Data points we hold from this source

Dow Jones Industrial Average · price decline800 points
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com